<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02136121</url>
  </required_header>
  <id_info>
    <org_study_id>001</org_study_id>
    <nct_id>NCT02136121</nct_id>
  </id_info>
  <brief_title>Prospective Investigation of Robotic Single-port System</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intuitive Surgical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intuitive Surgical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the feasibility of representative urologic procedures as measured by the rate of
      conversions
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the feasibility as measured by the rate of conversions</measure>
    <time_frame>Intra Operative</time_frame>
    <description>Rate of Conversion to Open approach</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative surgical outcomes</measure>
    <time_frame>From admission to discharge from the hospital for the primary procedure typically up to 7 days</time_frame>
    <description>Perioperative surgical outcomes length of hospital stay- From admission to discharge from the hospital for the primary procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative Surgical outcomes</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Rate of Transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative Surgical Outcomes</measure>
    <time_frame>30 day, 1 year , 2 year and 3 year follow up</time_frame>
    <description>Procedure specific wound complications , infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative - Continence</measure>
    <time_frame>1 year, 2 year and 3 year follow up</time_frame>
    <description>Continence measured by use of pads</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative Surgical Outcome- potency</measure>
    <time_frame>1 , 2 and 3 year follow up</time_frame>
    <description>Potency rate administered by International Index of Erectile Function patient questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Prostate and Kidney Cancer</condition>
  <arm_group>
    <arm_group_label>da Vinci Sp Surgical System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>da Vinci Sp Surgical System - Robotic - assisted single-port surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>da Vinci Sp Surgical System - Robotic</intervention_name>
    <description>robotic assisted laparoscopic single-port system</description>
    <arm_group_label>da Vinci Sp Surgical System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prostatectomy:

          -  Patients age 18-75 years

          -  BMI &lt;=35 kg/m2

          -  Confirmed localized adenocarcinoma of the prostate

          -  Suitable for minimally invasive prostate cancer surgery

        Nephrectomy:

          -  Patient age 18-75 years

          -  BMI &lt;=35 kg/m2

          -  Kidney disease amenable to nephrectomy or partial nephrectomy

          -  Suitable for minimally invasive kidney surgery

        Exclusion Criteria:

        Untreated active infection (includes local kidney infection)

          -  Vulnerable population (ex: prisoners, mentally disabled)

          -  Severe concomitant illness that drastically shortens life expectancy or increases risk
             of therapeutic interventions (i.e., cancer)

          -  Anatomy unsuitable for endoscopic visualization or minimally invasive surgery

          -  Patient with second primary cancer

          -  Extensive previous abdominal surgery

          -  Prior radiation treatment for prostate or kidney cancer

          -  Patient with distant metastasis

          -  Complex renal vascular anatomy

          -  Patient with kidney cancer - stage T3 or N+ M+ **

          -  Horseshoe kidney**

          -  Previous ipsilateral kidney surgery **- specific to kidney surgery -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnold Villers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital HURIEZ, CHRU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jihad Kaouk, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital HURIEZ, CHRU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2014</study_first_submitted>
  <study_first_submitted_qc>May 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2014</study_first_posted>
  <last_update_submitted>May 8, 2014</last_update_submitted>
  <last_update_submitted_qc>May 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

